Related Experiment Video
Updated: Jun 10, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients
Riccardo Accioli1,2, Pietro Enea Lazzerini1,2, Viola Salvini1,2
1Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.
Insights
Interleukin-6 (IL-6) elevation in severe COVID-19 patients is linked to temporary delays in heart conduction. This finding highlights the role of inflammation in cardiac events and supports anti-inflammatory treatments.
Area of Science:
- Cardiology
- Infectious Diseases
- Electrophysiology
Background:
- Severe COVID-19 is associated with increased risk of atrioventricular blocks (AVBs) and mortality.
- Uncontrolled inflammation, particularly elevated interleukin-6 (IL-6), is implicated in COVID-19's cardiac effects.
- IL-6 may directly impact cardiac electrophysiology.
Purpose of the Study:
- To assess the acute impact of IL-6 changes on electrocardiographic indices of atrioventricular conduction in severe COVID-19.
- To investigate PR-interval and PR-segment behavior during active COVID-19 and recovery.
- To determine the association between PR-indices and IL-6 levels over time.
Main Methods:
- Studied PR-interval and PR-segment in severe COVID-19 patients during active disease and recovery.
- Monitored circulating IL-6 levels over time.
- Analyzed correlations between PR-indices and IL-6 levels, controlling for confounding factors.
Main Results:
- Severe COVID-19 patients exhibited significant PR-interval and PR-segment prolongation during active illness.
- These atrioventricular conduction delays were transient, normalizing during recovery.
- PR-indices correlated significantly with IL-6 levels, independent of cardiac strain or medications.
Conclusions:
- Elevated IL-6 in severe COVID-19 is associated with significant, transient atrioventricular conduction delays.
- These delays may increase the risk of severe AVBs and short-term mortality.
- Findings support anti-IL-6 therapies for severe COVID-19.
Background:
Severely ill patients with coronavirus disease 2019 (COVID-19) show an increased risk of new-onset atrioventricular blocks (AVBs), associated with high rates of short-term mortality. Recent data suggest that the uncontrolled inflammatory activation observed in these patients, specifically interleukin (IL)-6 elevation, may play an important pathogenic role by directly affecting cardiac electrophysiology. The aim of our study was to assess the acute impact of IL-6 changes on electrocardiographic indices of atrioventricular conduction in severe COVID-19.
Methods:
We investigated (1) the behavior of PR-interval and PR-segment in patients with severe COVID-19 during active phase and recovery, and (2) their association with circulating IL-6 levels over time.
Results:
During active disease, COVID-19 patients showed a significant increase of PR-interval and PR-segment. Such atrioventricular delay was transient as these parameters rapidly normalized during recovery. PR-indices significantly correlated with circulating IL-6 levels over time. All these changes and correlations persisted also in the absence of laboratory signs of cardiac strain/injury or concomitant treatment with PR-prolonging drugs, repurposed or not.
Conclusions:
Our study provides evidence that in patients with severe COVID-19 and high-grade systemic inflammation, IL-6 elevation is associated with a significant delay of atrioventricular conduction, independent of concomitant confounding factors. While transient, such alterations may enhance the risk of severe AVB and associated short-term mortality. Our data provide further support to current anti-inflammatory strategies for severe COVID-19, including IL-6 antagonists.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:05Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Acute Coronary Syndrome III: Diagnostic studies
Pericarditis II: Clinical features and Diagnostic Tests
Endocarditis II: Clinical features and Diagnostic Tests